The 2022 MedTech Contract Manufacturing Report

Alira Health in collaboration with MassMEDIC

Publications
Category:
Published on:
March 28, 2022
Written by:
Carlo Stimamiglio, Campbell Roellig, Alice Scala, Brian Johnson

2021 was a remarkable year for the global medical device industry. Just as healthcare systems were learning to cope with the enduring effects of the pandemic, ramping up procedures, and product demand, device manufacturers were hit by the most severe supply chain crisis in decades. 

  • The MedTech industry expanded by +16.8%, driven by the catch-up of elective procedures and the prolonged demand for COVID-related diagnostics and consumables, mitigating the potentially disruptive impact of such a crunch in the supply-demand dynamic. 
  • Outsourced manufacturers also benefitted from the general market recovery since the flat 2020 performance. The US CDMO market, the focus of this report, lagged with a +12.9% aggregate performance, its growth potential constrained by these macro-challenges. 
  • During the last two volatile years, the OEMs’ long-term pursuit of supply chain efficiencies slowed down, in favor of efforts aimed at increasing global capacity, inventories and securing the continuity of product supplies. 
  • Despite the widespread growth across most segments of MedTech and the positive medium-term outlook for outsourcing organizations, many factors threaten the sustainability of the medical device manufacturing industry. 

Our analysis investigates these continuing trends and their meaning for medical device CDMOs and their capital sponsors. 

Fill in the form below to download the ” The 2022 MedTech Contract Manufacturing Report”. Have questions? Reach out to us at [email protected] 

Related news

Publications May 27, 2022
The Impact of Chip Shortage on the MedTech Sector and RAS Players
Discover the three factors driving the chip shortage, the impact, and what’s next for Robotic and MedTech industry at large.
CDMO MedTech Robotcs
News May 11, 2022
Alira Health Acquires RedCrow, an Equity Crowdfunding Platform for Healthcare Startups
We acquired RedCrow, an alternative investment platform that provides individual investors with easy access to expert-vetted healthcare start-ups. The financial terms of the transaction(...)
MedTech Patient Engagement Pharma
Events May 9, 2022
7e Journée start-up innovantes du dispositif médical
Clinical Digital Health Market Access MedTech Research & Development
Uncategorized May 6, 2022
U.S. and European Clinical Development for Asian MedTech Startups
This webinar will focus on the U.S. FDA and EU MDR/IVDR regulatory pathways and strategies for medical device startups based in the Asia Pacific.
Clinical MedTech
Uncategorized April 13, 2022
U.S. and European Regulatory Strategies for Asian MedTech Startups
This webinar will focus on the U.S. FDA and EU MDR/IVDR regulatory pathways and strategies for medical device startups based in the Asia Pacific.
MedTech Regulatory
Publications April 8, 2022
Cheat Sheet: MDCG Guidance on Medical Device Classification
Assigning the proper class to a medical device (MD) is one of the most important activities carried out by a manufacturer. Read Alira Health's cheat sheet MDCG Guidance on Medical Device(...)
MedTech Regulatory
Uncategorized April 6, 2022
Webinar Replay: Capital Raising from U.S. and Europe for Asian MedTech Startups
Replay of our recent webinar co-hosted by APACMed and Alira Health focused on helping Asia Pacific-based MedTech start-ups scale their businesses beyond APAC to the U.S. and Europe.
MedTech
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.